<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="between COVID-19â€&quot;bearing gangliosides and peripheral nerve glycolipids was addressed. Elevated" exact="Creatine" post="Kinase (&amp;gt;10,000) is reported in 10% of COVID-19â€&quot;infected patients;"/>
 <result pre="have been hypogeusia (in 5.6%), hyposmia (5.1%), and very high" exact="creatine" post="kinase (CK) levels, with myalgia (in 19.3%) indicating potential"/>
 <result pre="targeted cells.15 If benefit is confirmed and safety is established," exact="chloroquine" post="may be of added therapeutic value in future patients"/>
 <result pre="Most autoimmune neuromuscular patients are maintained on steroids, mycophenolate, or" exact="azathioprine" post="while most chronic inflammatory demyelinating polyneuropathy receive monthly IVIg."/>
 <result pre="acute inflammatory demyelinating polyneuropathy AMAN acute motor axonal neuropathy CK" exact="creatine" post="kinase CRP C-reactive protein GBS Guillain-BarrÃ© syndrome ICU intensive"/>
 <result pre="molecular modeling studies reveal a new mechanism of action of" exact="chloroquine" post="and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents202010.1016/j.ijantimicag.2020.105960."/>
 <result pre="studies reveal a new mechanism of action of chloroquine and" exact="hydroxychloroquine" post="against SARS-CoV-2 infection. Int J Antimicrob Agents202010.1016/j.ijantimicag.2020.105960. 16.VaduganathanM, VardenyO,"/>
 <result pre="34.DalakasMC, IllaI, PezeshkpourGH, LaukaitisJP, CohenB, GriffinJMitochondrial myopathy caused by long-term" exact="zidovudine" post="therapy. N Engl J Med1990;332:1098â€&quot;1105. 35.DalakasMCPeripheral neuropathy and antiretroviral"/>
</results>
